Moderna to deliver up to 125 million doses of COVID-19 vaccine globally in first quarter

by



[ad_1]

FILE PHOTO: Vials with a sticker reading, “COVID-19 / Coronavirus Vaccine / Injection Only” and a medical syringe are seen in front of a Moderna logo displayed in this illustration taken October 31, 2020. REUTERS / Dado Ruvic / Drawing

(Reuters) – Moderna Inc said Thursday that it plans to have between 100 million and 125 million doses of its experimental COVID-19 vaccine globally in the first quarter of 2021.

The company said 85 million to 100 million of these doses would be available in the United States, including 15 to 25 million outside the country.

The first-quarter doses are between 500 million and up to 1 billion doses that the company plans to manufacture globally in 2021, Moderna said.

Results from an early trial showed that the vaccine, mRNA-1273, produced high levels of binding and neutralizing antibodies that decreased slightly over time, but remained high in all participants three months after vaccination. recall, the company said.

Shares of the drugmaker were down about 2% to $ 154.4 after the bell.

Reporting by Dania Nadeem in Bengaluru; Edited by Devika Syamnath

[ad_2]

Source link